Mounjaro is the brand name under which tirzepatide is sold in Australia. It is a GLP-1 and GIP receptor medicine used for chronic weight management and is TGA registered for this purpose.
Mounjaro is prescription only. A doctor reviews medical history, current medications and individual circumstances before it is considered as part of a broader weight management or metabolic health plan.